Sandoz Group AG (SDZ) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.114x

Based on the latest financial reports, Sandoz Group AG (SDZ) has a cash flow conversion efficiency ratio of 0.114x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF1.07 Billion ≈ $1.35 Billion USD) by net assets (CHF9.38 Billion ≈ $11.87 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SDZ equity financing ratio to measure how much of total assets are equity-financed.

Sandoz Group AG - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Sandoz Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Sandoz Group AG's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Sandoz Group AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sandoz Group AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nokia Oyj
HE:NOKIA
0.030x
Vodafone Group Plc
F:VODJ
0.104x
Kellanova
NYSE:K
0.117x
Centene Corp
NYSE:CNC
0.167x
Dover Corporation
NYSE:DOV
0.026x
Chaozhou Three-circle Group Co Ltd
SHE:300408
0.041x
Hannover Rück SE
F:HNR1
0.128x
Teledyne Technologies Incorporated
NYSE:TDY
0.022x

Annual Cash Flow Conversion Efficiency for Sandoz Group AG (2020–2025)

The table below shows the annual cash flow conversion efficiency of Sandoz Group AG from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Sandoz Group AG (SDZ) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF9.38 Billion
≈ $11.87 Billion
CHF1.59 Billion
≈ $2.02 Billion
0.170x +111.37%
2024-12-31 CHF8.16 Billion
≈ $10.32 Billion
CHF656.00 Million
≈ $829.36 Million
0.080x +113.76%
2023-12-31 CHF8.65 Billion
≈ $10.94 Billion
CHF325.31 Million
≈ $411.28 Million
0.038x -100.00%
2022-12-31 CHF77.14K
≈ $97.52K
CHF1.17 Billion
≈ $1.48 Billion
15142.076x +9097643.39%
2021-12-31 CHF7.44 Billion
≈ $9.40 Billion
CHF1.24 Billion
≈ $1.57 Billion
0.166x +10.25%
2020-12-31 CHF6.83 Billion
≈ $8.63 Billion
CHF1.03 Billion
≈ $1.30 Billion
0.151x --

About Sandoz Group AG

SW:SDZ Switzerland Drug Manufacturers - Specialty & Generic
Market Cap
$34.99 Billion
CHF27.68 Billion CHF
Market Cap Rank
#915 Global
#17 in Switzerland
Share Price
CHF63.96
Change (1 day)
-3.88%
52-Week Range
CHF44.71 - CHF73.26
All Time High
CHF73.26
About

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of ac… Read more